new version V2017

Description Results

     

  • Group by...

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

renal-cell carcinoma (advanced)

METEOR, 2015cabozantinibeverolimus after VEGFR-targeted therapy failure Risk of bias SuggestingNCT01865747
CABOSUN, 2017cabozantinibsunitinibfirst-line therapy in patients with intermediate- or poor-risk Exploratory SuggestingNCT01835158



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons